The two tumor types with the highest number of RET fusion were lung adenocarcinoma and thyroid papillary carcinoma and they had prevalence rates of 1.14% (455/39922) and 9.09% (109/1199), respectively. This evidence concerns the gene RET and lung adenocarcinoma.